Serum IgA is a reliable biomarker of prior RSV infection in children under two years of age, a multinational study has ...

Depemokimab has been approved by the MHRA as the first and only biologic with twice-yearly dosing to treat asthma and severe ...

BSAC’s National OPAT Conference 2025 captured the evolution of OPAT as a cornerstone of modern infection management across ...

Microplastics can alter the gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer, ...

The 2025 ERS Congress highlighted the emerging challenges and innovations reshaping respiratory medicine, as Ravijyot Saggu ...

Significant unmet needs among people with RA-ILD have been identified in a recent survey, with clear gaps in the services ...

Patients with chronic hand eczema often have limited effective and well-tolerated topical treatment options, a real-world ...

Clinical advantage observed in refractory atopic dermatitis with lebrikizumab plus topical corticosteroids where ciclosporin ...

Profs Carl Philpott and Claire Hopkins discuss how the MACRO trial challenges long-held assumptions about chronic ...

Managing the future risks of type 2 diabetes and cancer in people with prediabetes should be tailored to the age of ...

Dr Chiara Re and Prof Grant Stewart discuss the UK’s first one-stop renal mass biopsy clinic for suspected renal cancer and ...

Regional and demographic variations persist in melanoma BRAF testing and patients with these tumours experience poorer five-year survival.